|
|
Volumn 46, Issue 8, 2002, Pages 2662-2664
|
|
In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZITHROMYCIN;
CLARITHROMYCIN;
CLINDAMYCIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
ERYTHROMYCIN;
GENTAMICIN;
LEVOFLOXACIN;
LINEZOLID;
OXACILLIN;
OXAZOLIDINONE DERIVATIVE;
POSIZOLID;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ACETAMIDE DERIVATIVE;
ANTIINFECTIVE AGENT;
OXAZOLE DERIVATIVE;
ARTICLE;
BACTERIAL STRAIN;
BACTERIUM ISOLATE;
COAGULASE NEGATIVE STAPHYLOCOCCUS;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PRIORITY JOURNAL;
STAPHYLOCOCCUS AUREUS;
ANTIBIOTIC RESISTANCE;
COMPARATIVE STUDY;
DRUG EFFECT;
HUMAN;
MICROBIOLOGICAL EXAMINATION;
MICROBIOLOGY;
STAPHYLOCOCCUS INFECTION;
ACETAMIDES;
ANTI-INFECTIVE AGENTS;
COMPARATIVE STUDY;
DRUG RESISTANCE, MICROBIAL;
HUMAN;
MICROBIAL SENSITIVITY TESTS;
OXAZOLES;
OXAZOLIDINONES;
STAPHYLOCOCCAL INFECTIONS;
STAPHYLOCOCCUS AUREUS;
SUPPORT, NON-U.S. GOV'T;
ANTI-BACTERIAL AGENTS;
HUMANS;
|
|
EID: 0035991983
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.46.8.2662-2664.2002 Document Type: Article |
|
Times cited : (12)
|
|
References (12)
|
